Cargando…

Quantitative tumor burden imaging parameters of the spleen at MRI for predicting treatment response in patients with acute leukemia

OBJECTIVES: To study the value of standardized volume and intravoxel incoherent motion (IVIM) parameters of the spleen based on tumor burden for predicting treatment response in newly diagnosed acute leukemia (AL). METHODS: Patients with newly diagnosed AL were recruited and underwent abdominal IVIM...

Descripción completa

Detalles Bibliográficos
Autores principales: Bian, Wenjin, Zhang, Jianling, Huang, Qianqian, Niu, Weiran, Li, Jianting, Song, Xiaoli, Cui, Sha, Zheng, Qian, Niu, Jinliang, Zhou, Xiaohong Joe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550618/
https://www.ncbi.nlm.nih.gov/pubmed/37810872
http://dx.doi.org/10.1016/j.heliyon.2023.e20348
_version_ 1785115582155194368
author Bian, Wenjin
Zhang, Jianling
Huang, Qianqian
Niu, Weiran
Li, Jianting
Song, Xiaoli
Cui, Sha
Zheng, Qian
Niu, Jinliang
Zhou, Xiaohong Joe
author_facet Bian, Wenjin
Zhang, Jianling
Huang, Qianqian
Niu, Weiran
Li, Jianting
Song, Xiaoli
Cui, Sha
Zheng, Qian
Niu, Jinliang
Zhou, Xiaohong Joe
author_sort Bian, Wenjin
collection PubMed
description OBJECTIVES: To study the value of standardized volume and intravoxel incoherent motion (IVIM) parameters of the spleen based on tumor burden for predicting treatment response in newly diagnosed acute leukemia (AL). METHODS: Patients with newly diagnosed AL were recruited and underwent abdominal IVIM diffusion-weighted imaging within one week before the first induction chemotherapy. Quantitative parameters of magnetic resonance imaging (MRI) included the standardized volume (representing volumetric tumor burden) and IVIM parameters (standard apparent diffusion coefficient [sADC]; pure diffusion coefficient [D]; pseudo-diffusion coefficient [D(∗)]; and pseudo-perfusion fraction [f], representing functional tumor burden) of the spleen. Clinical biomarkers of tumor burden were collected. Patients were divided into complete remission (CR) and non-CR groups according to the treatment response after the first standardized induction chemotherapy, and the MRI and clinical parameters were compared between the two groups. The correlations of MRI parameters with clinical biomarkers were analyzed. Multivariate logistic regression was performed to determine the independent predictors for treatment response. Receiver operating characteristic curves were used to analyze the predicted performance. RESULTS: 76 AL patients (CR: n = 43; non-CR: n = 33) were evaluated. Standardized spleen volume, sADC, D, f, white blood cell counts, and lactate dehydrogenase were significantly different between CR and non-CR groups (all p < 0.05). Standardized spleen volume, sADC, and D were correlated with white blood cell and lactate dehydrogenase, and f was correlated with lactate dehydrogenase (all p < 0.05). Standardized spleen volume (hazard ratio = 4.055, p = 0.042), D (hazard ratio = 0.991, p = 0.027), and f (hazard ratio = 1.142, p = 0.008) were independent predictors for treatment response, and the combination of standardized spleen volume, D, and f showed more favorable discrimination (area under the curve = 0.856) than individual predictors. CONCLUSION: Standardized volume, D, and f of the spleen could be used to predict treatment response in newly diagnosed AL, and the combination of morphological and functional parameters would further improve the predicted performance. IVIM parameters of the spleen may be viable indicators for evaluating functional tumor burden in AL.
format Online
Article
Text
id pubmed-10550618
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105506182023-10-06 Quantitative tumor burden imaging parameters of the spleen at MRI for predicting treatment response in patients with acute leukemia Bian, Wenjin Zhang, Jianling Huang, Qianqian Niu, Weiran Li, Jianting Song, Xiaoli Cui, Sha Zheng, Qian Niu, Jinliang Zhou, Xiaohong Joe Heliyon Research Article OBJECTIVES: To study the value of standardized volume and intravoxel incoherent motion (IVIM) parameters of the spleen based on tumor burden for predicting treatment response in newly diagnosed acute leukemia (AL). METHODS: Patients with newly diagnosed AL were recruited and underwent abdominal IVIM diffusion-weighted imaging within one week before the first induction chemotherapy. Quantitative parameters of magnetic resonance imaging (MRI) included the standardized volume (representing volumetric tumor burden) and IVIM parameters (standard apparent diffusion coefficient [sADC]; pure diffusion coefficient [D]; pseudo-diffusion coefficient [D(∗)]; and pseudo-perfusion fraction [f], representing functional tumor burden) of the spleen. Clinical biomarkers of tumor burden were collected. Patients were divided into complete remission (CR) and non-CR groups according to the treatment response after the first standardized induction chemotherapy, and the MRI and clinical parameters were compared between the two groups. The correlations of MRI parameters with clinical biomarkers were analyzed. Multivariate logistic regression was performed to determine the independent predictors for treatment response. Receiver operating characteristic curves were used to analyze the predicted performance. RESULTS: 76 AL patients (CR: n = 43; non-CR: n = 33) were evaluated. Standardized spleen volume, sADC, D, f, white blood cell counts, and lactate dehydrogenase were significantly different between CR and non-CR groups (all p < 0.05). Standardized spleen volume, sADC, and D were correlated with white blood cell and lactate dehydrogenase, and f was correlated with lactate dehydrogenase (all p < 0.05). Standardized spleen volume (hazard ratio = 4.055, p = 0.042), D (hazard ratio = 0.991, p = 0.027), and f (hazard ratio = 1.142, p = 0.008) were independent predictors for treatment response, and the combination of standardized spleen volume, D, and f showed more favorable discrimination (area under the curve = 0.856) than individual predictors. CONCLUSION: Standardized volume, D, and f of the spleen could be used to predict treatment response in newly diagnosed AL, and the combination of morphological and functional parameters would further improve the predicted performance. IVIM parameters of the spleen may be viable indicators for evaluating functional tumor burden in AL. Elsevier 2023-09-21 /pmc/articles/PMC10550618/ /pubmed/37810872 http://dx.doi.org/10.1016/j.heliyon.2023.e20348 Text en © 2023 The Authors. Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Bian, Wenjin
Zhang, Jianling
Huang, Qianqian
Niu, Weiran
Li, Jianting
Song, Xiaoli
Cui, Sha
Zheng, Qian
Niu, Jinliang
Zhou, Xiaohong Joe
Quantitative tumor burden imaging parameters of the spleen at MRI for predicting treatment response in patients with acute leukemia
title Quantitative tumor burden imaging parameters of the spleen at MRI for predicting treatment response in patients with acute leukemia
title_full Quantitative tumor burden imaging parameters of the spleen at MRI for predicting treatment response in patients with acute leukemia
title_fullStr Quantitative tumor burden imaging parameters of the spleen at MRI for predicting treatment response in patients with acute leukemia
title_full_unstemmed Quantitative tumor burden imaging parameters of the spleen at MRI for predicting treatment response in patients with acute leukemia
title_short Quantitative tumor burden imaging parameters of the spleen at MRI for predicting treatment response in patients with acute leukemia
title_sort quantitative tumor burden imaging parameters of the spleen at mri for predicting treatment response in patients with acute leukemia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550618/
https://www.ncbi.nlm.nih.gov/pubmed/37810872
http://dx.doi.org/10.1016/j.heliyon.2023.e20348
work_keys_str_mv AT bianwenjin quantitativetumorburdenimagingparametersofthespleenatmriforpredictingtreatmentresponseinpatientswithacuteleukemia
AT zhangjianling quantitativetumorburdenimagingparametersofthespleenatmriforpredictingtreatmentresponseinpatientswithacuteleukemia
AT huangqianqian quantitativetumorburdenimagingparametersofthespleenatmriforpredictingtreatmentresponseinpatientswithacuteleukemia
AT niuweiran quantitativetumorburdenimagingparametersofthespleenatmriforpredictingtreatmentresponseinpatientswithacuteleukemia
AT lijianting quantitativetumorburdenimagingparametersofthespleenatmriforpredictingtreatmentresponseinpatientswithacuteleukemia
AT songxiaoli quantitativetumorburdenimagingparametersofthespleenatmriforpredictingtreatmentresponseinpatientswithacuteleukemia
AT cuisha quantitativetumorburdenimagingparametersofthespleenatmriforpredictingtreatmentresponseinpatientswithacuteleukemia
AT zhengqian quantitativetumorburdenimagingparametersofthespleenatmriforpredictingtreatmentresponseinpatientswithacuteleukemia
AT niujinliang quantitativetumorburdenimagingparametersofthespleenatmriforpredictingtreatmentresponseinpatientswithacuteleukemia
AT zhouxiaohongjoe quantitativetumorburdenimagingparametersofthespleenatmriforpredictingtreatmentresponseinpatientswithacuteleukemia